(MGA) Mega Uranium - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA58516W1041

MGA: Uranium, Mining, Exploration, Investment

Mega Uranium Ltd. (TO:MGA) is a uranium exploration and investment company with a focus on developing uranium properties in strategic regions. The company primarily operates in Canada and Australia, holding significant interests in the Georgetown project in Queensland, Australia, and the Redport project in Western Australia. These projects are in various stages of exploration and development, with a focus on advancing towards production. The company also maintains a portfolio of uranium investments, diversifying its exposure to the uranium market. Formerly known as Maple Minerals Corp., Mega Uranium Ltd. was renamed in October 2005 and has been actively involved in the uranium sector since its incorporation in 1990. Headquartered in Toronto, Canada, the company is well-positioned to capitalize on the growing demand for nuclear energy and the increasing interest in uranium as a clean energy source.

The companys technical and fundamental data indicate a stock trading at CAD 0.26 as of the latest close, with an average 20-day volume of 368,957 shares. The stock is currently below its key moving averages, with the SMA 20 at 0.29, SMA 50 at 0.31, and SMA 200 at 0.33. The Average True Range (ATR) of 0.02 reflects low volatility in recent trading sessions. From a fundamental perspective, Mega Uranium has a market capitalization of CAD 104.15 million, with a price-to-book ratio of 0.58, indicating the stock is trading below its book value. The return on equity (RoE) is negative at -5.13%, reflecting current challenges in profitability.

3-Month Forecast: Based on the technical and fundamental data, Mega Uraniums stock is expected to remain range-bound in the near term, with potential downside pressure if it fails to breach the SMA 50 resistance level of 0.31. The low ATR suggests limited volatility, with price movements likely confined between CAD 0.24 and CAD 0.32. Fundamentally, the companys focus on advancing its uranium projects could drive long-term value, but in the short term, market sentiment toward uranium equities will remain a key driver of stock performance.

Additional Sources for MGA Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MGA Stock Overview

Market Cap in USD 72m
Sector Energy
Industry Uranium
GiC Sub-Industry Coal & Consumable Fuels
IPO / Inception

MGA Stock Ratings

Growth Rating 42.1
Fundamental -31.7
Dividend Rating 0.25
Rel. Strength -24.1
Analysts -
Fair Price Momentum 0.25 CAD
Fair Price DCF -

MGA Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 1.0%

MGA Growth Ratios

Growth Correlation 3m -52.5%
Growth Correlation 12m -47.9%
Growth Correlation 5y 64%
CAGR 5y 20.88%
CAGR/Max DD 5y 0.36
Sharpe Ratio 12m -0.06
Alpha -47.56
Beta 1.306
Volatility 72.14%
Current Volume 82.6k
Average Volume 20d 245.1k
What is the price of MGA stocks?
As of May 01, 2025, the stock is trading at CAD 0.27 with a total of 82,580 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -10.00%, over three months by -20.59% and over the past year by -32.50%.
Is Mega Uranium a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Mega Uranium (TO:MGA) is currently (May 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -31.65 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MGA as of May 2025 is 0.25. This means that MGA is currently overvalued and has a potential downside of -7.41%.
Is MGA a buy, sell or hold?
Mega Uranium has no consensus analysts rating.
What are the forecast for MGA stock price target?
According to ValueRays Forecast Model, MGA Mega Uranium will be worth about 0.3 in May 2026. The stock is currently trading at 0.27. This means that the stock has a potential upside of +3.7%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.3 3.7%